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Salmonella enterica serovar Enteritidis (S. Enteritidis) is one of the ubiquitous Salmonella
serovars worldwide and a major cause of food-born outbreaks, which are often
associated with poultry and poultry derivatives. Here we report a nation-wide S.
Enteritidis clonal outbreak that occurred in Israel during the last third of 2015. Pulsed
field gel electrophoresis and whole genome sequencing identified genetically related
strains that were circulating in Israel as early as 2008. Global comparison linked this
outbreak strain to several clinical and marine environmental isolates that were previously
isolated in California and Canada, indicating that similar strains are prevalent outside of
Israel. Phenotypic comparison between the 2015 outbreak strain and other clinical and
reference S. Enteritidis strains showed only limited intra-serovar phenotypic variation in
growth in rich medium, invasion into Caco-2 cells, uptake by J774.1A macrophages,
and host cell cytotoxicity. In contrast, significant phenotypic variation was shown
among different S. Enteritidis isolates when biofilm-formation, motility, invasion into
HeLa cells and uptake by THP-1 human macrophages were studied. Interestingly, the
2015 outbreak clone was found to possess superior intra-macrophage replication ability
within both murine and human macrophages in comparison to the other S. Enteritidis
strains studied. This phenotype is likely to play a role in the virulence and host-pathogen
interactions of this emerging clone.
Keywords: Salmonella enterica, Enteritidis, outbreak, food born infection, virulence, pathogenicity, intracellular
replication, gastroenteritis
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INTRODUCTION
The bacterial species Salmonella enterica is a Gram-negative,
facultative intracellular human and animal pathogen responsible
for a significant public health concern worldwide (Galanis et al.,
2006). S. enterica is a highly diverse species that includes
more than 2,600 different serovars (biotypes). These serovars
are classified into six taxonomic subspecies with high genetic
similarity (Edwards et al., 2002). Various (∼1500) Salmonella
serovars belonging to Subspecies I are known to be associated
with mammals and avian hosts and accountable for the
majority (∼99%) of the Salmonella infections in humans. Non-
typhoidal Salmonella serovars (NTS) normally cause in humans
a self-limited gastroenteritis associated with acute intestinal
inflammation and diarrhea (Zhang et al., 2003). Salmonella
infection is still one of the most common causes of food-borne
illnesses and a leading cause of diarrheal diseases in developed
and developing countries. 93.8 million cases of gastroenteritis
due to NTS infection are estimated annually, resulting in
approximately 155,000 deaths (Majowicz et al., 2010). In the USA
alone, one million domestically acquired Salmonella-associated
foodborne illnesses are reported each year, with more than 19,000
hospitalizations and at least 378 deaths, more than any other
bacterial pathogen (Scallan et al., 2011).
Salmonella enterica serovar Enteritidis (S. Enteritidis) is one of
the ubiquitous Salmonella serovars worldwide. In the last decade,
an increase in the number of S. Enteritidis infections has been
reported in the USA (Chai et al., 2012), Canada (Nesbitt et al.,
2012), and the European Union (ECDC, 2009), such that S.
Enteritidis has become the most frequently reported Salmonella
serovar. Investigations of outbreaks as well as sporadic cases
were able to repeatedly link S. Enteritidis infections with poultry
and poultry derivatives. It has been estimated that approximately
64% of S. Enteritidis clinical cases are due to contaminated
eggs and 18% are due to poultry products (Velge et al., 2005;
Gould et al., 2013). S. Enteritidis is therefore a major cause of
outbreaks responsible for 32% of all salmonellosis outbreaks with
a confirmed serotype in the USA (Gould et al., 2013).
Like other S. enterica serovars, S. Enteritidis pathogenicity
is largely determined by the ability of this pathogen to invade
non-phagocytic cells and survive (often grow) within professional
phagocytic cells, like macrophages and dendritic cells [reviewed
in (Gal-Mor et al., 2014)]. While in most cases, NTS infections
in humans cause gastroenteritis, occasionally NTS infections
can result in an extra-intestinal invasive disease, with clinical
manifestations of bacteremia and focal systemic infections.
Recently we showed that while the average invasive (systemic)
rate of NTS infections in Israel is 3.6%, S. Enteritidis has a
significantly higher chance to cause an invasive disease (Marzel
et al., 2014), thus increasing the public health concern associated
with this particular serovar.
Here we report a recent S. Enteritidis national outbreak,
which occurred in Israel during the last third of 2015. Whole
genome sequencing (WGS) and comparison with global isolates
of S. Enteritidis revealed a close genetic similarity with a domestic
2008 clinical isolate, but also with several isolates that were
obtained from marine origins in the west coast of the USA and
Canada, indicating that genetically related strains are circulating
outside of Israel. A broad physiological and virulence-associated
phenotypic characterization of this outbreak strain demonstrated
a prominent ability to replicate within macrophages that is likely
to affect the virulence potential of this strain.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Salmonella Enteritidis strains used in this study are listed in
Table 1. Salmonella cultures were routinely maintained in liquid
or agar Lennox Luria-Bertani (LB; BD Difco) and were grown at
37◦C in a shaker incubator rotating at 250 rpm.
Pulsed-Field Gel Electrophoresis
Pulsed-field gel electrophoresis analysis was carried out as was
previously described (Gal-Mor et al., 2012) and according to the
CDC PulseNet protocol standardized for S. enterica (Ribot et al.,
2006). XbaI and SpeI digested Salmonella DNA embedded in
agarose plugs were analyzed by PFGE at 14◦C in a CHEF DR III
system (Bio-Rad) using the following protocol: Voltage, 6 V/cm
for 19 h; initial pulse, 2 s; final pulse, 54 s; angle, 120◦; in a
0.5 × Tris-borate-EDTA buffer. S. Braenderup strain H9812 was
used as a molecular standard for this analysis.
Motility Assay
Salmonella cultures grown for overnight in LB broth at 37◦C were
used for motility measurements. 10 µl from each culture were
placed in the center of LB 0.3% agar plates and incubated for 5 h at
37◦C without being inverted. Motility halo radius was measured
with a ruler.
Biofilm Formation
Overnight cultures grown in LB (to OD600 4.5) were diluted
1:100 into fresh medium and 150 µl were added into cell culture
treated 96-well microplates (Greiner bio-one). Negative control
included LB broth only. The plates were incubated at 28◦C for
96 h. Planktonic cells were discarded and attached cells were fixed
for 2 h at 60◦C. Fixed bacteria were stained with 150 µl of 0.1%
Crystal Violet for 10 min at room temperature. The plates were
washed with phosphate buffered saline (PBS) and the dye bound
to the adherent bacteria was re-solubilized with 150 µl of 33%
acetic acid. The optical density of each tube was measured at
560 nm.
Tissue Cultures
All cell lines were purchased from the American Type Culture
Collection (ATCC) and were cultured at 37◦C in a humidified
atmosphere with 5% CO2. The human colonic adenocarcinoma
Caco-2 cell line was grown in Dulbecco’s modified Eagle
medium (DMEM)–F-12 medium (Biological Industries, Israel)
supplemented with 20% fetal bovine serum (FBS) and 2 mM
L-glutamine. The murine macrophage-like J774.1A and the
human epithelial HeLa cells were both maintained in a
high-glucose (4.5 g/liter) DMEM (Biological Industries, Israel)
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TABLE 1 | Bacterial strains and clinical isolates used in the study.
Strain Isolation date Source PFGE outbreak pattern (Y/N) Obtained from
S. Enteritidis 24352 11.06.2008 blood N Sheba Medical Center
S. Enteritidis 37007∗ 01.09.2008 blood Y Sheba Medical Center
S. Enteritidis 49906 27.11.2008 blood N Sheba Medical Center
S. Enteritidis 51765 11.12.2008 blood N Sheba Medical Center
S. Enteritidis 44519 24.09.2010 blood N Sheba Medical Center
S. Enteritidis 43527 30.10.2011 blood N Sheba Medical Center
S. Enteritidis 44325 06.11.2011 blood N Sheba Medical Center
S. Enteritidis 130135377 24.08.2013 blood N Sheba Medical Center
S. Enteritidis 130138950 20.09.2013 blood N Sheba Medical Center
S. Enteritidis 130139439 24.09.2013 blood N Sheba Medical Center
S. Enteritidis 140113933 01.04.2014 blood N Sheba Medical Center
S. Enteritidis 14011035 07.01.2015 blood N Sheba Medical Center
S. Enteritidis 150118463∗ 24.04.2015 blood Y Sheba Medical Center
S. Enteritidis 150315155† 15.06.2015 urine N Sheba Medical Center
S. Enteritidis 150131087† 19.07.2015 blood N Sheba Medical Center
S. Enteritidis 150136120 18.08.2015 blood Y Sheba Medical Center
S. Enteritidis 150145602 16.10.2015 blood Y Sheba Medical Center
S. Enteritidis 150146098 20.10.2015 blood Y Sheba Medical Center
S. Enteritidis 150148241 03.11.2015 blood Y Sheba Medical Center
S. Enteritidis 150149413 11.11.2015 blood Y Sheba Medical Center
S. Enteritidis 150149475∗† 11.11.2015 blood Y Sheba Medical Center
S. Enteritidis 150150208 16.11.2015 blood Y Sheba Medical Center
S. Enteritidis 150152213 29.11.2015 blood Y Sheba Medical Center
S. Enteritidis 15047444 30.11.2015 blood N Sheba Medical Center
S. Enteritidis 150153497† 08.12.2015 blood N Sheba Medical Center
S. Enteritidis PT4† N/A N/A N/A SGSC4901 reference strain
S. Enteritidis 665110208† 04.08.07 stool N/A 2007 outbreak strain
∗strain was sequenced. †strains used in phenotypic assays. SGSC, Salmonella genetic Stock Center, the University of Calgary.
supplemented with 10% heat-inactivated FBS, 1 mM pyruvate,
and 2 mM L-glutamine. The human myelogenous leukemia
THP-1 cell line was cultured in a RMPI 1640 (Biological
Industries, Israel) complemented with 2-mercaptoethanol to
a final concentration of 0.05 mM, 2 mM L-glutamine, 1mM
pyruvate, 1% MEM non-essential amino acids, and 20% FBS.
Adhesion, Invasion, and Intracellular
Replication Assays
Eighteen hours prior to bacterial infection, epithelial cells, and
macrophages were seeded at 5 × 104 and 2.5 × 105 cells/ml,
respectively, in a 24-well tissue culture dish. Experiments were
carried out using the gentamicin protection assay as previously
described (Elhadad et al., 2015). Epithelial cells were infected at
a multiplicity of infection (MOI) of ∼1:50 with late logarithmic
phase Salmonella cultures and macrophages were infected at
an MOI of ∼1:10 with cultures that were grown overnight to
the stationary phase. Immediately after the infection, cells were
centrifuged for 5 min at 500 rpm at room temperature. At the
indicated time points post infection (p.i.), cells were washed three
times with phosphate-buffered saline (PBS) and extracted using
lysis buffer (containing 0.1% SDS, 1% Triton X-100 in PBS).
Following host cells lysis, serial dilutions of the infected cell
lysate were plated onto LB agar plates and incubated at 37◦C
for bacterial enumeration. Salmonella invasion was calculated by
the number of intracellular Salmonella CFUs at 2 h p.i. divided
by the infecting inoculum, while intracellular replication was
determined by the number of intracellular Salmonella CFUs
at 24 h p.i. divided by the number of invading Salmonella
(as determined at 2 h p.i).
Adhesion was determined as was recently described (Azriel
et al., 2016) using cytochalasin D (Sigma-Aldrich), which inhibits
actin cytoskeleton rearrangement and bacterial cell invasion in an
actin-dependent manner. Host cells were incubated with 1µg/ml
cytochalasin D 1 h before the infection. Then, Salmonella cultures
were added and allowed to adhere the cells for 30 min in the
presence of 1 µg/ml cytochalasin D. Infected cells were washed
four times with PBS and harvested using lysis buffer (as above).
Adherent Salmonella were estimated by the number of bacterial
CFUs found in association with host cells at 30 min post infection
(p.i.) divided by the CFU of the infecting inoculum.
Cytotoxicity Assay
J774A.1 cells were seeded at 2.5 × 105 cells/ml in a 24-well
tissue culture dish and infected with Salmonella cultures grown to
stationary phase at MOI∼ 1:10. Cell supernatants were collected
4.5 and 20 h p.i. and analyzed for lactate dehydrogenase (LDH)
release using the CytoTox 96 Non-Radioactive Cytotoxicity
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Assay (Promega) according to manufactures instructions. Briefly,
50 µl of the CytoTox 96 reagent were added to 50 µl cells
supernatant and incubated for 15 min at 37◦C. Stop solution
(50 µl) was added and the absorbance was recorded at 490 nm.
Uninfected cells that were lysed by the Lysis Solution (0.8%
TritonX-100) were used as positive control and medium collected
from uninfected cells was used as negative control. Relative
cytotoxicity was calculated as the proportion between LDH
release from the infected cells (Experimental LDH Release) and
supernatant LDH from the positive control (maximum LDH
release) that was set to 100%.
Whole Genome Sequencing and
Bioinformatics
Whole genome shotgun assemblies for S. Enteritidis isolates
150149475, 37007, and 150118463 were generated at the
Technion Genome Center (Haifa, Israel) using MiSeq platform
and 500 cycles of Illumina’s paired end chemistry to a depth
of 1191, 382, and 337-fold coverage, respectively. De novo
assembly was done using CLC-Genomics Workbench 6.05 (CLC-
bio). All of these whole Genome Shotgun projects have been
deposited at DDBJ/ENA/GenBank under the accession numbers
listed in Table 2. All publically available Salmonella genomes
were obtained from PATRIC website1. Pairwise alignments of
S. Enteritidis P125109 (as a reference) with each one of the
strains was generated using the Mauve tool (Rissman et al.,
2009). The pairwise alignments were analyzed using custom
scripts to create a pseudomultiple alignment, where putative
orthologous bases to each S. Enteritidis P125109 position were
determined. This alignment was used to determine a SNP matrix
using custom scripts. Whenever raw reads were available for
isolates, reads were aligned to the S. Enteritidis P125109 genome
using Bowtie-2 (Langmead and Salzberg, 2012). Variant detection
was implemented in comparison with the reference strain using
SAMtools (Li et al., 2009) and custom scripts. Only bases with
a Phred score of >30 (0.1% error) in each read were used to
call a consensus base, and consensus bases with a score of >60
(0.0001% error) were used to call variants. The resultant SNP
matrix was further trimmed to remove sites that were not reliably
called in 99% of the analyzed strains. Maximum likelihood trees
were generated using FastTree (Liu et al., 2011) and the SNP
matrix generated above.
Statistics
ANOVA with Dunnett’s Multiple Comparison Test was used
to determine differences between data sets. Z-test was used to
1http://patricbrc.org
determined statistical significant between proportions. P < 0.05
was considered statistically significant.
Ethics
The study was approved by the Institutional Review Board of the
Sheba Medical Center (approval number 2915-16-SMC). Clinical
isolates obtained from patients were anonymized, processed
using isolate number only and were not associated with any
identifying details.
RESULTS AND DISCUSSION
The Emergence of S. Enteritidis in Israel
during 2015
The national prevalence of S. Enteritidis in Israel was rather
stable from the mid-1990s until recently, accountable for about
20% of all Salmonella infections in humans (Gal-Mor et al.,
2010; Marzel et al., 2014). Nonetheless, starting in August
2015, multiple clinical laboratories across the country have
reported a sharp increase in the prevalence of S. Enteritidis.
Integrated data from four medical centers located in the north
(Galilee and Poriya) and in the center (Wolfson and Sheba) of
Israel indicated a fourfold increase (p < 0.05) in S. Enteritidis
infections during 2015 compared with the previous years
2007 to 2014 (Figure 1). These results are also in agreement
with data reported to the Israel Center for Disease Control
(ICDC) during October–December 2015 by other sentinel
FIGURE 1 | Salmonella enterica serovar Enteritidis emergence in Israel
during 2015. The proportion (in %) of S. Enteritis from all Salmonella enterica
serovars is shown for years 2007–2015. Pooled data include the serotype of
638 Salmonella isolates that were collected from four Israeli medical centers
(Galilee, Poriya, Wolfson, and Sheba), located in the north and the center of
the country. Salmonella serotyping was determined at the National Salmonella
Reference Center according to the White-Kauffmann-Le Minor scheme using
O- and H-antigen specific sera.
TABLE 2 | Sequencing and assembly parameters of the three S. Enteritidis sequenced isolates.
Isolate Coverage (×fold) Number of reads (M) Number of contigs N50 (bp) Genome size (Mb) Number of predicted ORFs Accession number
150149475 1191 11.58 269 489,802 4.78 4701 MAXX00000000
37007 382 7.21 43 477,839 4.76 4776 MAXY00000000
150118463 337 6.39 56 284,254 4.75 4725 MAXZ00000000
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FIGURE 2 | The 2015 S. Enteritidis emergence is attributed to a clonal
outbreak. (A) Thirteen S. Enteritidis strains isolated during 2015 from patients
who were hospitalized in the Sheba Medical Center were analyzed by PFGE
(Pulsed-field gel electrophoresis) using XbaI endonuclease. (B) Twelve clinical
(Continued)
FIGURE 2 | Continued
S. Enteritidis strains collected in Sheba during 2008–2014 and the 2015
outbreak clone (isolate 150149475 as a reference) were analyzed by PFGE
using XbaI endonuclease. (C) Strains that showed similar XbaI-PFGE profile
(and isolate 1501047444 as a negative control) were digested with a second
endonuclease, SpeI and analyzed by PFGE. DNA marker (Mr) was generated
by digestion of Salmonella enterica serovar Braenderup H9812 DNA with XbaI
(B) or speI (C). Strains showing the dominant 2015 outbreak PFGE profile are
indicated with an asterisk.
laboratories. Most of these 2015 S. Enteritidis isolates were
susceptible to the tested antibiotics chloramphenicol, ceftriaxone,
ampicillin, trimethoprim/sulfamethoxazole, ofloxacin, and
ciprofloxacin. These data suggested an abnormal increase
in the prevalence of this serovar in humans at the national
level.
To determine if the increased domestic prevalence of S.
Enteritidis was the result of a clonal outbreak, PFGE was
performed using XbaI endonuclease on 13 S. Enteritidis isolates
from patients hospitalized in the Sheba Medical Center, during
2015 (Figure 2A) and 12 isolates from patients that were
hospitalized in the previous years during 2008–2014 (Figure 2B).
This analysis indicated that 9/13 of the 2015 S. Enteritidis isolates
presented a similar PFGE profile that was distinct from most of
the 2008–2014 isolates profiles.
Interestingly, the XbaI-PFGE pattern of the dominate 2015
outbreak clone was found to be similar to the clinical strain 37007,
which was isolated from a patient blood sample at September
2008. To verify these results, nine isolates that showed similar
XbaI-PFGE profile (and isolate 15047444 that showed a distinct
profile during the outbreak as a negative control) were further
examined using SpeI digest followed by PFGE (Figure 2C).
These results confirmed genetic similarity between 8/9 of the
2015 isolates and demonstrated a clonal structure of the 2015
S. Enteritidis outbreak, which has occurred between August and
November 2015. Furthermore, this analysis suggested a genetic
similarity between the 2015 outbreak and the 2008 clinical isolate,
37007.
Whole Genome Sequencing and
Phylogenetic Analysis of the 2015
S. Enteritidis Outbreak Clone
Whole genome sequencing using MiSeq platform (500 cycle
paired end run) was applied to determine the complete
DNA sequence of a representative 2015 outbreak isolate
150149475 (from November 2015) and its related 2008 isolate,
37007. Another S. Enteritidis isolate with similar PFGE
profile from April 2015 (isolate number 150118463) was also
sequenced in order to determine its genetic relatedness to the
outbreak. Assembly of the WGS reads indicated a genome
size of 4.75–4.78 Mb and confirmed their serotyping as
S. enterica serovar Enteritidis. Table 2 shows the sequencing
and the assembly parameters of these three S. Enteritidis
genomes.
Phylogenetic analysis of the above three genomes in the
context of 408 S. Enteritis genomes isolated from various sources
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around the globe, supported a close genetic similarity between
isolate 150149475 and 37007, but positioned isolate 150118463
on a close, yet distinct branch (Figure 3), despite the fact
that all three isolates shared very similar PFGE profiles. This
discrepancy exhibits the disadvantage of PFGE over WGS as a
molecular epidemiology tool, and indicates that the earliest strain
in the outbreak that we have analyzed was isolated in August
2015 (150136120) and that the April isolated strain (150118463)
is likely to be unrelated to this outbreak. Furthermore, this
phylogenetic analysis showed that the 2015 S. Enteritidis
outbreak clone is genetically related to several clinical (blood)
and marine mammals (sea otter and sea lions) strains that were
isolated in California USA and to a shellfish isolate from Canada
(Supplementary Figure S1), indicating that closely genetic strains
to the 2015 outbreak clone can be found outside from Israel.
Physiological Characterization of the
Outbreak Strain
To characterize the 2015 outbreak clone on the phenotypic
level, growth, motility, and biofilm formation of the sequenced
isolate 150149475 were compared to those of a reference strain
(S. Enteritidis PT4) and additional clinical strains, including a
2007 outbreak isolate (665110208) and three sporadic strains that
were isolated in Israel prior to 2015 (3150131087, 150153497,
and 150315155). Growth in rich LB medium at 37◦C was very
similar among all S. Enteritidis isolates tested, including the
2015 outbreak strain (Figure 4A). The 2015 outbreak strain
(150149475 marked in black line or bars in Figure 4) and the
S. Enteritidis reference strain (PT4) displayed similar motility
(Figure 4B) and biofilm formation (Figure 4C), whereas the
other strains tested were variable in these phenotypes.
FIGURE 3 | The phylogenetic relationship of the 2015 Israeli outbreak strain with global S. Enteritidis isolates. The 2015 S. Enteritidis outbreak strain
(150149475), the 2008 clinical isolate (37007) and the April 2015 clinical isolate (150118463) were compared to S. Enteritidis P125109 (reference strain marked in
green) in the context of 408 global S. Enteritidis sequenced strains. The maximum clade credibility tree was constructed based on SNPs using FastTree. The internal
nodes show local support values with the Shimodaira-Hasegawa test as computed by FastTree. A zoom-in image of the boxed area, showing the close neighbors of
the Israeli sequenced strains is presented in Supplementary Figure S1.
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Virulence-Associated Phenotypes
Characterization
To further understand the potential virulence of the 2015
outbreak clone we studied the ability of isolate 150149475 to
adhere and invade host cells. While the strains were differed
in host cell adherence (Figure 5A), no significant difference
was found between the 2015 outbreak clone and the other S.
Enteritidis strains for invasion into human epithelial Caco-2 cell-
line (Figure 5B) and uptake by murine J774A.1 macrophages
(Figure 5D). Intra-serovar variation was also found in the
ability to invade HeLa cells (Figure 5C), and in the uptake
by THP-1 human macrophages (Figure 5E). However, in all
of these virulence-associated phenotypes, the capability of the
2015 outbreak strain was similar to the one of the S. Enteritidis
PT4 (the reference strain), with no marked characteristics that
phenotypically distinct the 2015 outbreak strain from other S.
Enteritidis isolates.
The 2015 S. Enteritidis Outbreak Strain
Presents an Elevated Intra-macrophages
Replication
The ability of S. enterica to cause systemic disease is dependent
upon survival and replication within macrophages (Valdez et al.,
2009). Salmonella serovars and even different strains of the same
serovar vary in their intra-macrophage survival and host cell
cytotoxicity (Schwan et al., 2000; Suez et al., 2013). Therefore,
we studied the intracellular replication of these strains within
phagocytic cells. We found that the 2015 outbreak strain had a
significantly higher intracellular replication phenotype compared
to all of the other tested S. Enteritidis strains including PT4, both
in murine J774A.1 (Figure 6A) and human THP-1 (Figure 6B)
macrophages. While the average replication rate of the tested S.
Enteritidis strains was 41 ± 9-fold over 24 h in THP-1 cells,
the intra-macrophage growth of the 2015 outbreak strain was
more than 90-fold. Similarly, the average intracellular growth in
J774A.1 cells of S. Enteritidis strains was 1.19 ± 0.5-fold, while
the 2015 outbreak clone growth was 5.5-fold over 24 h infection.
Previously, it has been shown that Salmonella spp. can induce
cytotoxicity in macrophages at least in part due to a Salmonella-
mediated apoptotic response (Chen et al., 1996; Monack et al.,
1996). Hence, the observed high intra-macrophage CFU counts
for isolate 150149475 could have been the result of either elevated
replication or low macrophages killing by this outbreak strain. To
test the possibility that the differences in intracellular replication
are attributed to variation in cytotoxicity or Salmonella-induced
apoptosis (Schwan et al., 2000), cytotoxicity assay was performed.
This experiment showed low and similar J774A.1 killing by
all Salmonella Enteritidis strains including isolate 150149475 at
4.5 h post infection (Figure 6C). Higher, but still similar levels
of cytotoxicity between all strains were also observed at 20 h
p.i. (data not shown), indicating that the elevated intracellular
replication in macrophages of the 2015 outbreak isolate is not due
to a particularly low cytotoxicity of its host cells. We therefore
concluded from these results that in contrast to other phenotypes
tested, the 2015 outbreak strain shows a distinct ability to
replicate within professional phagocytic cells in vitro, which may
FIGURE 4 | Physiological characterization of the 2015 outbreak strain.
(A) The growth of the 2015 S. Enteritidis outbreak strain (150149475) was
studied in rich LB medium in comparison to a reference strain (PT4) and four
other S. Enteritidis clinical isolates (665110208, 150131087, 150153497,
150315155). Optical density at 600 nm over 24 h at 37◦C is shown. (B)
Motility of the above strains as measured on semi-solid (0.3% agar) plates
following 5 h incubation at 37◦C. Each bar shows the mean ± standard error
of the mean (SEM) of four biological replicates. (C) S. Enteritidis strains were
grown under biofilm-inducing conditions (in LB medium lacking NaCl at 28◦C)
for 96 h. Biofilm formation was determined using Crystal Violet staining. The
bars represent the mean of six biological repeats with the SEM shown by the
error bars. ANOVA with Dunnett’s Multiple Comparison Test was used to
define differences between data sets. ns, not significant; ∗p<0.05;
∗∗p<0.001; ∗∗∗p<0.0001.
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FIGURE 5 | Virulence-associated phenotypic characterization of the 2015 outbreak strain. S. Enteritidis strains were grown in LB medium at 37◦C and used
to infect epithelial or macrophage cell-lines as specified in the “Material and Methods” Section. (A) Adhesion to Caco-2 cells was assayed in the presence of
cytochalasin D and is presented as the percentage of cell-associated Salmonella from the initial Salmonella inoculum used to infect the cells. Invasion into Caco-2
cells (B) or HeLa cells (C) and uptake by J774A.1 murine macrophages (D) or THP-1 human macrophages (E) was studied using the gentamicin protection assay
and is shown as the percentage of intracellular bacteria (CFU) recovered at 2 h p.i from the infecting inoculum. Graph bars represent the mean and SEM of 3–4
biological replicates. ns, not significant; ∗p<0.05; ∗∗p<0.001; ∗∗∗p<0.0001.
suggest a higher virulence potential of this clone compared to
other S. Enteritidis tested strains.
SUMMARY AND CONCLUSION
During August to November 2015 we identified an abnormal
increase in S. Enteritidis prevalence in Israel. PFGE analysis using
two restriction enzymes confirmed the occurrence of a clonal
outbreak responsible for the increase in S. Enteritidis infections
in humans. WGS linked the 2015 outbreak strain with a clinical
isolate from Israel isolated in September 2008. WGS also revealed
a high genetic similarity to different clinical and environmental
isolates obtained from clinical and marine origins in the west
coast of USA and in Canada, indicating that the 2015 outbreak
clone may not be endemic to Israel.
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FIGURE 6 | The 2015 outbreak strain presents elevated
intra-macrophage replication phenotype. S. Enteritidis strains grown in
LB medium to the stationary phase were used to infect macrophages in an
MOI of 10. Intracellular replication of S. Enteritidis strains was determined in
J774A.1 (A) or THP-1 (B) macrophages using the gentamicin protection
assay. Bars show the mean fold-change in the number of intracellular
Salmonella at 24 h p.i relative to 2 h p.i in 3–4 independent infections with
SEM shown by the error bars. (C) Cytotoxicity of J774A.1 cells was tested
4.5 h post infection with S. Enteritidis strains. Cytotoxicity was determined by
lactate dehydrogenase (LDH) release detected by colorimetric absorbance
assay. Lysed uninfected cells were used as positive control and their LDH
release was set to 100%. Medium collected from uninfected cells was used
as negative control. Each bar shows the mean of three independent infections
with SEM shown by the error bars. ns, not significant; ∗p<0.05; ∗∗p<0.001;
∗∗∗p<0.0001.
Phenotypic comparison between the 2015 outbreak strain
with reference and other clinical S. Enteritidis strains
showed only limited intra-serovar phenotypic variation in
rich medium growth, invasion into CaCo-2 cells, uptake
by J774.1A macrophage-like cells, and host cell cytotoxicity.
In contrast, significant phenotypic variation occurred in
biofilm-formation, motility, invasion into HeLa, and uptake
by THP-1 human macrophages. Notably, the 2015 outbreak
strain demonstrated significantly higher ability to replicate
in both murine and human macrophages compared with
reference strains. Since intra-macrophage replication plays
a key role in Salmonella pathogenicity, it is likely that this
phenotype contributes to the virulence potential of this
strain.
Differences in the ability of Salmonella strains to replicate
within macrophages could be due to varied composition or
expression of numerous genes involved in Salmonella intra-
macrophage growth. More than a decade ago, Eriksson et al.
(2003) demonstrated that the transcription of more than 900 S.
Typhimurium genes is changed during murine macrophage-like
J774-A.1 cells infection and a recent RNA-seq analysis identified
change in the expression of more than 1700 transcriptional
start sites during S. Typhimurium infection of RAW 264.7
macrophage-like cells (Srikumar et al., 2015), demonstrating the
genetic complexity underlying this phenotype.
Although the source of this 2015 S. Enteritidis outbreak
have not been identified by the Israeli health authorities, future
surveillance for this strain, its epidemiology and its infection
outcome will provide important data, likely to shed more light
on the biology and the pathogenicity of this emerging clone.
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